Gene · 8900
Papers2,123
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,123
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of multi-omics biomarkers and construction of the novel prognostic model for hepatocellular carcinoma. | Sci Rep | 2022 | 35840618 | PubTator, text mining | PubMed |
| WNT signaling and cancer stemness. | Essays Biochem | 2022 | 35837811 | PubTator, text mining | PubMed |
| SARS-CoV-2 potential drugs, drug targets, and biomarkers: a viral-host interaction network-based analysis. | Sci Rep | 2022 | 35831333 | PubTator, text mining | PubMed |
| The trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine inhibits lipopolysaccharide-induced inflammation transcriptomic pathways and cytokine secretion in a macrophage cell model. | Toxicol In Vitro | 2022 | 35811015 | PubTator, text mining | PubMed |
| 5-Demethylnobiletin Inhibits Cell Proliferation, Downregulates ID1 Expression, Modulates the NF-κB/TNF-α Pathway and Exerts Antileukemic Effects in AML Cells. | Int J Mol Sci | 2022 | 35806401 | PubTator, text mining | PubMed |
| SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma: A Systematic Review and Pooled Analysis of Treatment Outcomes. | Cancers (Basel) | 2022 | 35805058 | PubTator, text mining | PubMed |
| Molecular Basis of Beckwith-Wiedemann Syndrome Spectrum with Associated Tumors and Consequences for Clinical Practice. | Cancers (Basel) | 2022 | 35804856 | PubTator, text mining | PubMed |
| Design, synthesis and molecular docking of new fused 1H-pyrroles, pyrrolo[3,2-d]pyrimidines and pyrrolo[3,2-e][1, 4]diazepine derivatives as potent EGFR/CDK2 inhibitors. | J Enzyme Inhib Med Chem | 2022 | 35801486 | PubTator, text mining | PubMed |
| Long noncoding RNA Smyca coactivates TGF-β/Smad and Myc pathways to drive tumor progression. | J Hematol Oncol | 2022 | 35794621 | PubTator, text mining | PubMed |
| Prognostic and therapeutic prediction by screening signature combinations from transcriptome-methylome interactions in oral squamous cell carcinoma. | Sci Rep | 2022 | 35794182 | PubTator, text mining | PubMed |
| Transient DUX4 expression in human embryonic stem cells induces blastomere-like expression program that is marked by SLC34A2. | Stem Cell Reports | 2022 | 35777358 | PubTator, text mining | PubMed |
| Epigenetic and Transcriptomic Regulation Landscape in HPV+ Cancers: Biological and Clinical Implications. | Front Genet | 2022 | 35774512 | PubTator, text mining | PubMed |
| Treatment of a recurrent ischial ulcer with injected exosomes. | J Surg Case Rep | 2022 | 35774473 | PubTator, text mining | PubMed |
| Transcriptional Regulation of ING5 and its Suppressive Effects on Gastric Cancer. | Front Oncol | 2022 | 35747809 | PubTator, text mining | PubMed |
| Evaluation of Galanin Expression in Colorectal Cancer: An Immunohistochemical and Transcriptomic Study. | Front Oncol | 2022 | 35707368 | PubTator, text mining | PubMed |
| LncRNA NEAT1 Promotes the Malignant Progression of Colorectal Cancer by Targeting ZEB1 via miR-448. | Technol Cancer Res Treat | 2022 | 35695254 | PubTator, text mining | PubMed |
| Tizoxanide Promotes Apoptosis in Glioblastoma by Inhibiting CDK1 Activity. | Front Pharmacol | 2022 | 35694267 | PubTator, text mining | PubMed |
| Beyond Surgical Treatment in Adenoid Cystic Carcinoma of the Head and Neck: A Literature Review. | Cancer Manag Res | 2022 | 35693117 | PubTator, text mining | PubMed |
| Low expression of cytosolic NOTCH1 predicts poor prognosis of breast cancer patients. | Am J Cancer Res | 2022 | 35693094 | PubTator, text mining | PubMed |
| ITRAQ-based quantitative proteomic analysis reveals that VPS35 promotes the expression of MCM2-7 genes in HeLa cells. | Sci Rep | 2022 | 35690672 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8900/papers?page=17